PMC:7396557 / 74437-74746 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T763","span":{"begin":0,"end":5},"obj":"CL:0000738"},{"id":"T764","span":{"begin":6,"end":11},"obj":"CL:0000738;UBERON:0000178"},{"id":"T765","span":{"begin":12,"end":16},"obj":"CL:0000738"},{"id":"T766","span":{"begin":33,"end":43},"obj":"CL:0000542"},{"id":"T69731","span":{"begin":0,"end":5},"obj":"CL:0000738"},{"id":"T14585","span":{"begin":6,"end":11},"obj":"CL:0000738;UBERON:0000178"},{"id":"T44392","span":{"begin":12,"end":16},"obj":"CL:0000738"},{"id":"T55314","span":{"begin":33,"end":43},"obj":"CL:0000542"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T402","span":{"begin":0,"end":16},"obj":"Body_part"},{"id":"T403","span":{"begin":12,"end":16},"obj":"Body_part"},{"id":"T404","span":{"begin":33,"end":43},"obj":"Body_part"},{"id":"T405","span":{"begin":51,"end":54},"obj":"Body_part"}],"attributes":[{"id":"A402","pred":"fma_id","subj":"T402","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A403","pred":"fma_id","subj":"T403","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A404","pred":"fma_id","subj":"T404","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A405","pred":"fma_id","subj":"T405","obj":"http://purl.org/sig/ont/fma/fma62863"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T206","span":{"begin":6,"end":11},"obj":"Body_part"}],"attributes":[{"id":"A206","pred":"uberon_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T701","span":{"begin":6,"end":11},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T702","span":{"begin":12,"end":16},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T51295","span":{"begin":152,"end":157},"obj":"Chemical"},{"id":"T19552","span":{"begin":192,"end":197},"obj":"Chemical"}],"attributes":[{"id":"A24493","pred":"chebi_id","subj":"T51295","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A18661","pred":"chebi_id","subj":"T19552","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}

{"project":"LitCovid-sentences","denotations":[{"id":"T551","span":{"begin":116,"end":246},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}

{"project":"LitCovid-PubTator","denotations":[{"id":"2128","span":{"begin":93,"end":96},"obj":"Gene"},{"id":"2129","span":{"begin":305,"end":308},"obj":"Gene"}],"attributes":[{"id":"A2128","pred":"tao:has_database_id","subj":"2128","obj":"Gene:1401"},{"id":"A2129","pred":"tao:has_database_id","subj":"2129","obj":"Gene:1401"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased. Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L: 7.12 ± 0.55 vs. 5.67 ± 0.51, p \u003c 0.05), and the levels of CRP "}